Tabbara Marina M, Riella Juliano, Gonzalez Javier, Gaynor Jeffrey J, Guerra Giselle, Alvarez Angel, Ciancio Gaetano
Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, United States.
Miami Transplant Institute, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, FL, United States.
Front Surg. 2024 Apr 24;11:1391971. doi: 10.3389/fsurg.2024.1391971. eCollection 2024.
A limiting factor in expanding the kidney donor pool is donor kidneys with renal tumors or cysts. Partial nephrectomy (PN) to remove these lesions prior to transplantation may help optimize organ usage without recurrence of malignancy or increased risk of complications.
We retrospectively analyzed all recipients of a living or deceased donor graft between February 2009 and October 2022 in which a PN was performed prior to transplant due to the presence of one or more concerning growths. Donor and recipient demographics, perioperative data, donor allograft pathology, and recipient outcomes were obtained.
Thirty-six recipients received a graft in which a PN was performed to remove suspicious masses or cysts prior to transplant. Majority of pathologies turned out to be a simple renal cyst (65%), followed by renal cell carcinoma (15%), benign multilocular cystic renal neoplasm (7.5%), angiomyolipoma (5%), benign renal tissue (5%), and papillary adenoma (2.5%). No renal malignancy recurrences were observed during the study period (median follow-up: 67.2 months). Fourteen complications occurred among 11 patients (30.6% overall) during the first 6mo post-transplant. Mean eGFR (± standard error) at 36 months post-transplant was 51.9 ± 4.2 ml/min/1.73 m ( = 23). Three death-censored graft losses and four deaths with a functioning graft and were observed.
PN of renal grafts with suspicious looking masses or cysts is a safe option to optimize organ usage and decrease the kidney non-use rate, with no observed recurrence of malignancy or increased risk of complications.
扩大肾供体库的一个限制因素是带有肾肿瘤或囊肿的供体肾脏。在移植前进行部分肾切除术(PN)以切除这些病变,可能有助于优化器官利用,同时不会出现恶性肿瘤复发或并发症风险增加的情况。
我们回顾性分析了2009年2月至2022年10月期间所有接受活体或尸体供体肾移植的受者,这些受者因存在一个或多个可疑肿物而在移植前接受了PN。获取了供体和受者的人口统计学数据、围手术期数据、供体同种异体肾病理以及受者的结局。
36名受者接受了在移植前进行PN以切除可疑肿物或囊肿的肾移植。大多数病理结果为单纯肾囊肿(65%),其次是肾细胞癌(15%)、良性多房囊性肾肿瘤(7.5%)、肾血管平滑肌脂肪瘤(5%)、良性肾组织(5%)和乳头状腺瘤(2.5%)。在研究期间(中位随访时间:67.2个月)未观察到肾恶性肿瘤复发。11名患者(总体发生率为30.6%)在移植后的前6个月出现了14例并发症。移植后36个月时的平均估算肾小球滤过率(±标准误差)为51.9±4.2ml/min/1.73m²(n = 23)。观察到3例死亡审查后的移植肾丢失以及4例移植肾功能正常时的死亡。
对带有可疑肿物或囊肿的肾移植进行PN是优化器官利用和降低肾脏弃用率的安全选择,未观察到恶性肿瘤复发或并发症风险增加。